On the Absurdity of "Legislating Discovery"
There are 7.1 billion reasons to be indignant over President Bush's avian flu preparedness plan: it's too expensive, it imposes unfunded mandates on the states, it includes questionable liability waivers for hospitals and vaccine manufacturers, it assigns Homeland Security to coordinate the response to any outbreak rather than Health and Human Services, and so on.
But here is what I consider to be the most outrageous part of the bill:
Where did this implicit notion come from that any medical breakthrough can simply be "bought" by throwing enough money at the medical establishment of this country? (SIDEBAR: Does anyone really think that Roche, the owner of Tamiflu and a non-U.S. company, is going to get any of that $2.8 billion? How about Chiron, the last major flu vaccine producer but whose facilities are in England and is being bought by another non-U.S. company, Novartis?)
We've been fighting a "War on Cancer" for 34 years and a "War on AIDS" for 20. The first Muscular Dystrophy Telethon was broadcast in 1966. Yet we still have cancer, AIDS and muscular dystrophy, even after having spent far more than $2.8 billion trying to cure them.
This political wishful thinking of "we can eradicate X in our lifetime" is of course not limited to medical research (e.g., "we can eradicate poverty in our lifetime"). And perhaps the idea that "it's just a matter of how much money" is a throwback to the Moon Landing. But I fear that is not the case.
We are dealing with the most anti-science, anti-intellectual political leadership of recent times and possibly of all time. Do we really need to sit every Washington politician down, one by one, and explain to them that avian flu vaccine is not something the government can simply requisition from Wal-Mart or Halliburton like a few million MRE's or a new space shuttle?
One of the first things every child has to learn is that "wishing won't make it so." And one of the first things every politician ought to learn is that "spending won't make it so, either."
Here's my counterproposal: Take that $2.8 billion, put it aside (dare I say "put it in a lockbox"?) and offer it as a bounty to whichever pharmaceutical company is first able to mass-produce a timely avian flu vaccine. If and only if someone can actually do it, then they claim the bounty and we get our money's worth; if not, then at least the money isn't wasted. But the investment risk will be on the private sector and not the taxpayer (and there would also be no danger of political favoritism in allocating the money). All the potential upside with none of the downside — now that's my kind of investment.
More thoughts from PoliBlog, Hammer of Truth, Corante.
But here is what I consider to be the most outrageous part of the bill:
The biggest share, $2.8 billion, would subsidize the rapid development of cell-based technology for making influenza vaccine — an investment that the United States' dwindling vaccine industry has been making only slowly.Here's the problem: the government can tax-and-spend $2.8 billion, or $2.8 trillion, to underwrite "cell-based technology for making influenza vaccine," but that doesn't mean you're going to get any.
Where did this implicit notion come from that any medical breakthrough can simply be "bought" by throwing enough money at the medical establishment of this country? (SIDEBAR: Does anyone really think that Roche, the owner of Tamiflu and a non-U.S. company, is going to get any of that $2.8 billion? How about Chiron, the last major flu vaccine producer but whose facilities are in England and is being bought by another non-U.S. company, Novartis?)
We've been fighting a "War on Cancer" for 34 years and a "War on AIDS" for 20. The first Muscular Dystrophy Telethon was broadcast in 1966. Yet we still have cancer, AIDS and muscular dystrophy, even after having spent far more than $2.8 billion trying to cure them.
This political wishful thinking of "we can eradicate X in our lifetime" is of course not limited to medical research (e.g., "we can eradicate poverty in our lifetime"). And perhaps the idea that "it's just a matter of how much money" is a throwback to the Moon Landing. But I fear that is not the case.
We are dealing with the most anti-science, anti-intellectual political leadership of recent times and possibly of all time. Do we really need to sit every Washington politician down, one by one, and explain to them that avian flu vaccine is not something the government can simply requisition from Wal-Mart or Halliburton like a few million MRE's or a new space shuttle?
One of the first things every child has to learn is that "wishing won't make it so." And one of the first things every politician ought to learn is that "spending won't make it so, either."
Here's my counterproposal: Take that $2.8 billion, put it aside (dare I say "put it in a lockbox"?) and offer it as a bounty to whichever pharmaceutical company is first able to mass-produce a timely avian flu vaccine. If and only if someone can actually do it, then they claim the bounty and we get our money's worth; if not, then at least the money isn't wasted. But the investment risk will be on the private sector and not the taxpayer (and there would also be no danger of political favoritism in allocating the money). All the potential upside with none of the downside — now that's my kind of investment.
More thoughts from PoliBlog, Hammer of Truth, Corante.
Related Posts (on one page):
Posted by Kip on
2 November 2005.



